Evaluation of Prothrombin Time and Activated Partial Thromboplastin Time in Antithrombotic-Treated Cardiac Patients: A Cross-Sectional Study from Sana'a City, Yemen. [PDF]
Vasc Health Risk ManagAmer AH, Al-Adhroey AH, Al-Shammakh AA.
europepmc +1 more source
Effect of Hyperthermia on Prothrombin Time (PT), International Normalized Ratio (INR), and Activated Partial Thromboplastin Time (APTT). [PDF]
CureusDevi J, Kakkar N, Sharma A.
europepmc +1 more source
Resolving Bivalirudin Interference on Fibrinogen Testing by the Use of Activated Carbon. [PDF]
J Clin Lab AnalDu J +5 more
europepmc +1 more source
The <i>in vitro</i> anticoagulant effect of abelacimab in healthy children. [PDF]
Res Pract Thromb HaemostLetunica N +6 more
europepmc +1 more source
Effects of coagulation dysfunction and platelet changes on rebleeding and prognosis in acute subdural hematoma. [PDF]
Am J Transl ResLi D, Wang P, Zhang X, Zhao K.
europepmc +1 more source
Heparin Anticoagulant Therapy and Its Monitoring. [PDF]
BiomoleculesReardon B +3 more
europepmc +1 more source
The Effect of Hepatitis B Infection on Levels of Fibrinogen, Protein C, and Protein S in Pregnant Women. [PDF]
J PregnancyKhalifah AA +10 more
europepmc +1 more source
Optimizing treatment for Waldenström macroglobulinemia-associated acquired von Willebrand syndrome: a case report and literature review. [PDF]
Front OncolShen K, Yang C, Ma H.
europepmc +1 more source